Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 3 days ago by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 3 days ago by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. Since 2000, Medicare, the publicly funded insurance program for seniors, has covered routine costs of clinical trial participation. But coverage for patients with private insurance differed by insurer and state, the researchers noted. Under the ACA, or Obamacare, however, private insurers had to cover "standard of care" costs of clinical trial participation as of 2014. For this study, the researchers analyzed more than 2,400 patient referrals to the Clinical Center for Targeted Therapy at ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Votrient, Avastin, Tarceva, Pancreatic Cancer, Tasigna, Sutent, Sprycel, Afinitor, Nexavar, Stomach Cancer, Carboplatin, Cisplatin, Cyclophosphamide

Many Terminal Cancer Patients Remain in Denial

Posted 4 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 4 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Avastin

Little Evidence That Vasectomy Raises Prostate Cancer Risk

Posted 5 days ago by Drugs.com

TUESDAY, July 18, 2017 – For men who have had or might undergo a vasectomy, there is good news: A major study finds scant evidence that the procedure raises their risk of prostate cancer. "At most, there is a trivial association between vasectomy and prostate cancer that is unlikely to be causal," concluded a team led by Dr. R. Jeffrey Karnes, of the Mayo Clinic in Rochester, Minn. The analysis, based on data from 53 studies on the subject, was published online July 17 in the journal JAMA Internal Medicine. As the researchers noted, couples who want to avoid unintended pregnancy often place the responsibility on the female partner. And sometimes, conception occurs despite the use of birth control pills or devices. In contrast, vasectomy has a very low risk of unintended pregnancy. And, "given the lower costs and lower risk of complications for vasectomy compared with [female] tubal ... Read more

Related support groups: Birth Control, Contraception, Prostate Cancer, Genitourinary Surgical and Other Conditions

'Observation' Best Option for Most Low-Risk Prostate Cancer

Posted 10 days ago by Drugs.com

THURSDAY, July 13, 2017 – Men with early stage prostate cancer who have surgery to remove their tumor do not live longer than those who receive no treatment at all, a long-running clinical trial has concluded. At the same time, nearly one in three men who had the surgery wound up with long-term complications, such as urinary incontinence and erectile dysfunction, said lead researcher Dr. Timothy Wilt. He is a clinical investigator with the Minneapolis Veterans Affairs Health Care System. Based on these findings, cancer experts should revise clinical guidelines so most men with low-risk prostate cancer receive no treatment, Wilt said. Instead, doctors should simply track the progress of their patient's slow-growing cancer by asking about signs and symptoms of disease progression. "Our results demonstrate that for the large majority of men with localized prostate cancer, selecting ... Read more

Related support groups: Surgery, Prostate Cancer, Diagnosis and Investigation, Genitourinary Surgical and Other Conditions

Are Big Men More Prone to Aggressive Prostate Cancer?

Posted 10 days ago by Drugs.com

THURSDAY, July 13, 2017 – The larger a man, the greater his risk of getting and dying from aggressive prostate cancer, a new study suggests. Every additional 4 inches of height increased a man's chances of being diagnosed with high-risk prostate cancer by 21 percent, and their odds of dying from prostate cancer by 17 percent, researchers found. The same held true regarding the size of a man's waist. Every 4-inch increase in waist circumference increased the odds of developing aggressive prostate cancer by 13 percent and the risk of dying from prostate cancer by 18 percent. "I definitely think these results encourage men to have a healthy weight, and to have more public health policies that prevent obesity," said lead researcher Aurora Perez-Cornago, a nutritional epidemiologist with the University of Oxford in England. Perez-Cornago and her colleagues came to their conclusions based on ... Read more

Related support groups: Obesity, Cancer, Prostate Cancer, Prostatitis, Diagnosis and Investigation

Do Blacks, Hispanics Get Low Quality Hospice Care?

Posted 18 days ago by Drugs.com

WEDNESDAY, July 5, 2017 – Hospice quality varies, with blacks and Hispanics often getting less desirable end-of-life care, a new study finds. Researchers surveyed thousands of caregivers whose loved ones died in hospice care. They found that minority patients were more likely to receive care in poorer quality hospices than white patients. They also said that family caregivers of black and Hispanic hospice patients were less likely to receive adequate emotional and religious support. "Our findings highlight the need to ensure that blacks and Hispanics have access to high-quality and culturally competent hospice services," said study lead author Rebecca Anhang Price, a senior policy researcher at the RAND Corp. "This is particularly important as people from these groups increase their use of hospice services," she added in a RAND news release. The report wasn't all bad news for ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Gastric Cancer

Some Prostate Drugs May Do Harm

Posted 29 Jun 2017 by Drugs.com

THURSDAY, June 29, 2017 – Popular hormone-based drugs for treating an enlarged prostate could increase men's risk of type 2 diabetes, heart disease or stroke, a new study suggests. A group of German men taking the drug Avodart (dutasteride) for three years wound up with higher blood sugar and cholesterol levels than men taking another class of prostate medication that does not affect male hormones, the researchers reported. "Our small study suggests there are really adverse effects on metabolic function from these drugs that has not been reported previously," said lead researcher Abdulmaged Traish. He is a professor of urology with the Boston University School of Medicine. But Dr. Ashutosh Tewari, chair of urology for the Icahn School of Medicine at Mount Sinai in New York City, said the new findings run counter to prior clinical trials of the drug, and do not warrant any change in use ... Read more

Related support groups: Benign Prostatic Hyperplasia (BPH), Prostate Cancer, Finasteride, Avodart, Prostatitis, Propecia, Jalyn, Dutasteride, Proscar, Dutasteride/tamsulosin, Prostate Tumor - Benign

Big Gap in Cancer Deaths Between Rich, Poor Countries

Posted 22 Jun 2017 by Drugs.com

WEDNESDAY, June 21, 2017 – Over the past few decades, death rates linked to cancer and heart disease have declined in most developed nations, thanks to more effective prevention strategies, early detection and greater access to quality health care. But the same isn't true for poorer counties where the number of people dying from cancer has either remained unchanged or continues to rise, researchers report. The international team of researchers assessed the impact that cancer has had on the life span of people between 40 and 84 years old from 1981 to 2010, and compared it to the effects that heart disease has had on life expectancy over the same time period. The scientists analyzed cancer death rates from national databases of 52 countries that belong to the World Health Organization. They considered deaths for all cancers combined, and also looked specifically at the deaths rates for ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer

Give Dad the Gift of Health on Father's Day

Posted 16 Jun 2017 by Drugs.com

FRIDAY, June 16, 2017 – The best present you can give your dad this Father's Day is to help him get healthy, according to a doctor specializing in men's health. "We tend to think men don't want to talk about their own health, but I find that's really not the case with most. Dads are much more open than you'd think to talk about their health," said Dr. Jesse Mills. He is director of The Men's Clinic at the University of California, Los Angeles. One way that children, no matter their age, can help dad is to become his workout buddy or at least be part of his exercise routine. "Even when dad is taking care of the kids, the kids don't have to be a roadblock for his exercise. Dads of toddlers can run while pushing the stroller, and stop at the playground with his kids mid-workout," Mills said in a university news release. Sleep is another important health habit for fathers. Men should get ... Read more

Related support groups: Obesity, Weight Loss, High Cholesterol, Prostate Cancer, Testicular Cancer

More Cancers Caught in Wealthy People

Posted 7 Jun 2017 by Drugs.com

WEDNESDAY, June 7, 2017 – Wealthy Americans are more likely to be diagnosed with some types of cancer than poor people, a new study finds. The reason: It's not because affluent people are more likely to get cancer, but rather because they undergo more medical tests, the researchers explained. The study authors analyzed data on four types of cancers (breast, prostate, melanoma and thyroid) in high-income counties (median annual income above $75,000) and low-income counties (median annual income less than $40,000). Rich counties had far higher diagnosis rates for the four cancers than poor counties, but the combined death rate was similar for both. That suggests rates of these cancers are actually similar in rich and poor counties, the researchers said. Several factors may explain higher diagnosis rates in rich counties, the researchers said. Affluent people may expect and demand more ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Gleevec, Rituxan, Lung Cancer, Isotretinoin, Colorectal Cancer

Reporting Symptoms Online to Docs Helps Cancer Patients Live Longer

Posted 4 Jun 2017 by Drugs.com

SUNDAY, June 4, 2017 – When people with advanced cancer report their symptoms to health care providers using an online program, they may live longer, a new study suggests. The benefit may come because the new online tool cuts any "lag time" between patients experiencing symptoms and their care team's response to those issues, the researchers said. "Patients receiving chemotherapy often have severe symptoms, but doctors and nurses are unaware of these symptoms up to half of the time," explained study author Dr. Ethan Basch, a professor of medicine at the University of North Carolina's Lineberger Comprehensive Cancer Center. Dr. Bruce Johnston, President-Elect of the American Society of Clinical Oncology (ASCO), said the new technology addresses a common problem in cancer care. "A lot of patients are reluctant to contact docs between visits – they may think, 'I don't feel too good, but ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Head and Neck Cancer

Drug Extends Lives of Patients With Advanced Prostate Cancer: Studies

Posted 4 Jun 2017 by Drugs.com

SATURDAY, June 3, 2017 – Men with advanced prostate cancer might be able to avoid chemotherapy by taking an additional anti-testosterone pill along with standard hormone therapy, a pair of new clinical trials show. The drug, abiraterone (Zytiga), lowered patients' risk of death by nearly 40 percent when added to standard androgen deprivation therapy, both studies found. Abiraterone also appeared to more than double the average time it took for a man's prostate cancer to progress, one of the studies reports. Doctors currently combine the chemotherapy drug docetaxel with hormone therapy to treat patients with advanced prostate cancer, where the cancer has spread to the bone or other parts of their body, the researchers said. Abiraterone now offers a reasonable alternative to chemotherapy for these men, said Dr. Sumanta Kumar Pal, an expert with the American Society of Clinical Oncology ... Read more

Related support groups: Testosterone, Prostate Cancer, AndroGel, Testim, Axiron, Androderm, Zytiga, Casodex, Depo-Testosterone, Bicalutamide, Xtandi, Fortesta, Testopel, Testopel Pellets, Abiraterone, Flutamide, Testim 5 g/packet, Delatestryl, Striant, Testosterone Topical

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Lupron, Premarin, ethinyl estradiol, Estrace, Lupron Depot, Zoladex, Estradiol Patch, Zytiga, view more... Casodex, Taxotere, Cenestin, Eligard, Enjuvia, cyclophosphamide, capecitabine, bicalutamide, Xtandi, flax, leuprolide, Menest, docetaxel, degarelix, Provenge, Firmagon, Trelstar, abiraterone, goserelin, Xofigo, Progynova, conjugated estrogens, Vantas, Flax Seed Oil, Supprelin LA, Trelstar LA, Trelstar Depot, flutamide, triptorelin, Thais, Sandrena, nilutamide, Premarin Intravenous, esterified estrogens, Jevtana, cabazitaxel, Zoladex 3-Month, sipuleucel-t, Lupron Depot 11.25 mg, Delestrogen, Cytadren, radium 223 dichloride, Viadur, histrelin, Estratab, mitoxantrone, estramustine, Novantrone, abarelix, diethylstilbestrol, Docefrez, Plenaxis, Nilandron, Thaissept, Progynova TS, Zumenon, Valergen, Eulexin, Estinyl, Emcyt, Primogyn Depot, aminoglutethimide, enzalutamide, Systen, Provames, Oromone, Stilphostrol